Cargando…
Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide
Aim: To study the long term benefits, toxicity and survival rate in patients with neuroendocrine tumors receiving multiple cycles of high activity In-111 Pentetreotide therapy. Moreover, our secondary aim was to evaluate the value of F-18 FDG PET-CT scan as prognostic indicator in this group of pati...
Autores principales: | Delpassand, Ebrahim S., Samarghandi, Amin, Mourtada, Jennifer Sims, Zamanian, Sara, Espenan, Gregory D., Sharif, Roozbeh, MacKenzie, Shawn, Kosari, Kambiz, Barakat, Omar, Naqvi, Shagufta, Seng, John E., Anthony, Lowell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364554/ https://www.ncbi.nlm.nih.gov/pubmed/22737186 http://dx.doi.org/10.7150/thno.3739 |
Ejemplares similares
-
False-positive (111)In-pentetreotide Uptake in Gastritis
por: Usmani, Sharjeel, et al.
Publicado: (2013) -
Sarcoidosis mimicking metastatic carinoid on indium-111 pentetreotide scintigraphy
por: Rafiei, Poyan, et al.
Publicado: (2015) -
Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors
por: Kubota, Kazuo, et al.
Publicado: (2014) -
(111)In-pentetreotide uptake in accessory spleen: A potential pitfall in somatostatin receptor scintigraphy
por: Salihoglu, Yavuz Sami, et al.
Publicado: (2016) -
Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.
por: O'Byrne, K. J., et al.
Publicado: (1994)